Ginger—Mechanism of action in chemotherapy-induced nausea and vomiting: A review

Critical Reviews in Food Science and Nutrition

Volumn 57, Issue 1, 2017, Pages 141-146

  Marx, Wolfgang ^a,b   Ried, Karin ^b   McCarthy, Alexandra L ^c   Vitetta, Luis ^d   Sali, Avni ^b   McKavanagh, Daniel ^d   Isenring, Liz ^a,d,e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b National Institute of Integrative Medicine   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d PRINCESS ALEXANDRA HOSPITAL   (Australia)

^e BOND UNIVERSITY   (Australia)

Author keywords

chemotherapy; CINV; Ginger; nausea; vomiting

Indexed keywords

CHEMOTHERAPY; PATIENT TREATMENT; PLANTS (BOTANY);

ACETYLCHOLINE RECEPTOR; BIOACTIVE COMPOUNDS; CINV; GASTROINTESTINAL MOTILITY; GINGER; MECHANISM OF ACTION; NAUSEA; VOMITING;

FOOD ADDITIVES;

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CATECHOL DERIVATIVE; FATTY ALCOHOL; GINGEROL; NONSTEROID ANTIINFLAMMATORY AGENT; SHOGAOL;

ANIMAL; BIOLOGICAL MODEL; CHEMICALLY INDUCED; CHEMISTRY; ETHNOPHARMACOLOGY; GINGER; HUMAN; METABOLISM; NAUSEA; PATHOPHYSIOLOGY; RHIZOME; VOMITING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIEMETICS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CATECHOLS; ETHNOPHARMACOLOGY; FATTY ALCOHOLS; GINGER; HUMANS; MODELS, BIOLOGICAL; NAUSEA; RHIZOME; VOMITING;

EID: 84991735389     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2013.865590     Document Type: Article

References (54)

1. H.Abdel-Aziz, T.Windeck, M.Ploch, and E.J.Verspohl, (2006). Mode of action of gingerols and shogaols on 5-HT3 receptors:Binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. Eur. J. Pharm. 530:136–143.
2. T.L.Abell, M.Camilleri, K.Donohoe, W.L.Hasler, H.C.Lin, A.H.Maurer, R.W.McCallum, T.Nowak, M.L.Nusynowitz, H.P.Parkman, P.Shreve, L.A.Szarka, W.J.Snape, Jr. and H.A.Ziessman, (2008). Consensus recommendations for gastric emptying scintigraphy:A joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am. J. Gastroenterol. 103:753–763.
3. M.S.Baliga, R.Haniadka, M.M.Pereira, J.J.D'Souza, P.L.Pallaty, H.P.Bhat, and S.Popuri, (2011). Update on the chemopreventive effects of ginger and its phytochemicals. Crit. Rev. Food Sci. Nutr. 51:499–523.
4. B.Bloechl-Daum, R.R.Deuson, P.Mavros, M.Hansen, and J.Herrstedt, (2006). Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J. Clin. Oncol. 24:4472–4478.
5. S.D.Caras, I.Soykan, V.Beverly, Z.Lin, and R.W.McCallum, (1997). The effect of intravenous vasopressin on gastric myoelectrical activity in human subjects. Neurogastroenterol. Motil. 9:151–156.
6. N.Carelle, E.Piotto, A.Bellanger, J.Germanaud, A.Thuillier, and D.Khayat, (2002). Changing patient perceptions of the side effects of cancer chemotherapy. Cancer. 95:155–163.
7. M.M.Cawley, and L.M.Benson, (2005). Current trends in managing oral mucositis. Clin. J. Oncol. Nurs. 9:584–592.
8. W.Davidson, L.Teleni, J.Muller, M.Ferguson, A.L.McCarthy, J.Vick, and E.Isenring, (2012). Malnutrition and chemotherapy-induced nausea and vomiting:Implications for practice. Oncol. Nurs. Forum. 39:E340–345.
9. E.Ernst, and M.H.Pittler, (2000). Efficacy of ginger for nausea and vomiting:A systematic review of randomized clinical trials. Br. J. Anaesth. 84:367–371.
10. R.D.Fisher, R.E.Rentschler, J.C.Nelson, T.E.Godfrey, and D.W.Wilbur, (1982). Elevation of plasma antidiuretic hormones (ADH) associated with chemotherapy-induced emesis in man. Cancer Treat. Rep. 66:25–29.
11. A.Grontved, T.Brask, J.Kambskard, and E.Hentzer, (1988). Ginger root against seasickness:A controlled trial on the open sea. Acta Otolaryngol. 105:45–49.
12. A.Grontved, and E.Hentzer, (1986). Vertigo-reducing effect of ginger root:A controlled clinical study. ORL J. Otorhi. Relat. Spec. 48:282–286.
13. K.Hashimoto, K.Satoh, P.Murata, B.Makino, I.Sakakibara, Y.Kase, A.Ishige, M.Higuchi, and H.Sasaki, (2002). Component of Zingiber officinale that improves the enhancement of small intestinal transport. Planta Med. 68:936–939.
14. P.J.Hesketh, (2005). Management of nausea and vomiting in cancer treatment:Introduction, scope of the problem. In:Management of Nausea and Vomiting in Cancer and Cancer Treatment, pp. 1–15. P.J.Hesketh, Ed., Jones and Bartlett, Sudbury, MA.
15. S.Holtmann, A.H.Clarke, H.Scherer, and M.Hohn, (1989). The antimotion sickness mechanism of ginger. A comparative study with placebo and dimenhydrinate. Acta Otolaryngol. 108:168–174.
16. M.L.Hu, C.K.Rayner, K.L.Wu, S.K.Chuah, W.C.Tai, Y.P.Chou, Y.C.Chiu, K.W.Chiu, and T.H.Hu, (2011). Effect of ginger on gastric motility and symptoms of functional dyspepsia. World J. Gastroenterol. 17:105–110.
17. Q.R.Huang, M.Iwamoto, S.Aoki, N.Tanaka, K.Tajima, J.Yamahara, Y.Takaishi, M.Yoshida, T.Tomimatsu, and Y.Tamai, (1991). Anti-5-hydroxytryptamine3 effect of galanolactone, diterpenoid isolated from ginger. Chem. Pharm. Bull. (Tokyo). 39:397–399.
18. M.Iwami, T.Shiina, H.Hirayama, T.Shima, T.Takewaki, and Y.Shimizu, (2011a). Inhibitory effects of zingerone, a pungent component of Zingiber officinale Roscoe, on colonic motility in rats. J. Nat. Med. 65:89–94.
19. M.Iwami, T.Shiina, H.Hirayama, and Y.Shimizu, (2011b). Intraluminal administration of zingerol, a nonpungent analogue of zingerone, inhibits colonic motility in rats. Biomed. Res. 32:181–185.
20. Y.Jiang, D.K.Turgeon, B.D.Wright, E.Sidahmed, M.T.Ruffin, D.E.Brenner, A.Sen, and S.M.Zick, (2012). Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer. Eur. J. Cancer Prev
21. M.S.Kim, W.D.Chey, C.Owyang, and W.L.Hasler, (1997). Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrhythmias in motion sickness. Am. J. Physiol. 272:G853–862.
22. H.Leventhal, D.V.Easterling, D.R.Nerenz, and R.R.Love, (1988). The role of motion sickness in predicting anticipatory nausea. J. Behav. Med. 11:117–130.
23. H.C.Lien, W.M.Sun, Y.H.Chen, H.Kim, W.Hasler, and C.Owyang, (2003). Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection. Am. J. Physiol. Gastrointest. Liver Physiol. 284:G481–489.
24. C.M.Lindley, and J.D.Hirsch, (1992). Nausea and vomiting and cancer patients' quality of life:A discussion of Professor Selby's paper. Br. J. Cancer Suppl. 19:S26–29.
25. C.M.Lindley, J.D.Hirsch, C.V.O'Neill, M.C.Transau, C.S.Gilbert, and J.T.Osterhaus, (1992). Quality of life consequences of chemotherapy-induced emesis. Qual. Life Res. 1:331–340.
26. A.W.Linnane, M.Kios, and L.Vitetta, (2007). Healthy aging:Regulation of the metabolome by cellular redox modulation and prooxidant signaling systems:The essential roles of superoxide anion and hydrogen peroxide. Biogerontology 8:445–467.
27. D.L.Longo, M.Wesley, D.Howser, S.M.Hubbard, T.Anderson, and R.C.Young, (1982). Results of a randomized double-blind crossover trial of scopolamine versus placebo administered by transdermal patch for the control of cisplatin-induced emesis. Cancer Treat Rep. 66:1975–1976.
28. W.M.Marx, L.Teleni, A.L.McCarthy, L.Vitetta, D.McKavanagh, D.Thomson, and E.Isenring, (2013). Ginger (Zingiber officinale) and chemotherapy-induced nausea and vomiting:A systematic literature review. Nutrit. Rev. 71:245–254.
29. Y.Masuda, H.Kikuzaki, M.Hisamoto, and N.Nakatani, (2004). Antioxidant properties of gingerol related compounds from ginger. Biofactors 21:293–296.
30. B.R.Meyer, V.O'Mara, and M.M.Reidenberg, (1987). A controlled clinical trial of the addition of transdermal scopolamine to a standard metoclopramide and dexamethasone antiemetic regimen. J. Clin. Oncol. 5:1994–1997.
31. G.H.Micklefield, Y.Redeker, V.Meister, O.Jung, I.Greving, and B.May, (1999). Effects of ginger on gastroduodenal motility. Int. J. Clin. Pharmacol. Ther. 37:341–346.
32. D.B.Mowrey, and D.E.Clayson, (1982). Motion sickness, ginger, and psychophysics. Lancet. 1:655–657.
33. J.A.Ojewole, (2006). Analgesic, antiinflammatory, and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats. Phytother. Res. 20:764–772.
34. D.Osoba, (2005). Impact of nausea and vomiting on health-related quality of life. In:Management of Nausea and Vomiting in Cancer and Cancer Treatment, pp. 99–118. P.J.Hesketh, Ed., Jones and Bartlett, Sudbury, MA.
35. S.Phillips, S.Hutchinson, and R.Ruggier, (1993). Zingiber officinale does not affect gastric emptying rate:A randomized, placebo-controlled, crossover trial. Anaesthesia. 48:393–395.
36. U.N.Prakash, and K.Srinivasan, (2010). Gastrointestinal protective effect of dietary spices during ethanol-induced oxidant stress in experimental rats. Appl. Physiol. Nutr. Metab. 35:134–141.
37. P.N.Ravindran, and K.N.Babu, (2004). In:Ginger:The Genus Zingiber, p. 86, Taylor & Francis, New York
38. J.A.Rudd, and P.L.R.Andrews, (2005). Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies. In:Management of Nausea and Vomiting in Cancer and Cancer Treatment, pp. 15–65, P.J.Hesketh, Ed., Jones and Bartlett, Sudbury, MA.
39. M.Schapira, J.Henrion, and F.R.Heller, (1990). The current status of gastric prokinetic drugs. Acta Gastroenterol Belg. 53:446–457.
40. R.Schmid, T.Schick, R.Steffen, A.Tschopp, and T.Wilk, (1994). Comparison of seven commonly used agents for prophylaxis of seasickness. J. Travel. Med. 1:203–206.
41. Z.V.Shariatpanahi, F.A.Taleban, M.Mokhtari, and S.Shahbazi, (2010). Ginger extract reduces delayed gastric emptying and nosocomial pneumonia in adult respiratory distress syndrome patients hospitalized in an intensive care unit. J. Crit. Care. 25:647–650.
42. S.S.Sharma, and Y.K.Gupta, (1998). Reversal of cisplatin-induced delay in gastric emptying in rats by ginger (Zingiber officinale). J. Ethnopharmacol. 62:49–55.
43. J.J.Stewart, M.J.Wood, C.D.Wood, and M.E.Mims, (1991). Effects of ginger on motion sickness susceptibility and gastric function. Pharmacology 42:111–120.
44. M.Sultani, A.M.Stringer, J.M.Bowen, and R.J.Gibson, (2012). Antiinflammatory cytokines:Important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis. Chemoth. Res. Pract. 2012:11
45. C.C.Sun, D.C.Bodurka, C.B.Weaver, R.Rasu, J.K.Wolf, M.W.Bevers, J.A.Smith, J.T.Wharton, and E.B.Rubenstein, (2005). Rankings and symptom assessments of side effects from chemotherapy:Insights from experienced patients with ovarian cancer. Support Care Cancer. 13:219–227.
46. R.Terry, P.Posadzki, L.K.Watson, and E.Ernst, (2011). The use of ginger (Zingiber officinale) for the treatment of pain:A systematic review of clinical trials. Pain Med. 12:1808–1818.
47. Y.Torii, H.Saito, and N.Matsuki, (1994a). Induction of emesis in Suncus murinus by pyrogallol, a generator of free radicals. Br. J. Pharm. 111:431–434.
48. Y.Torii, H.Saito, and N.Matsuki, (1994b). Induction of emesis in Suncus murinus by pyrogallol, a generator of free radicals. Br. J. Pharmacol. 111:431–434.
49. R.B.van Breemen, Y.Tao, and W.Li, (2011). Cyclooxygenase-2 inhibitors in ginger (Zingiber officinale). Fitoterapia. 82:38–43.
50. C.D.Wood, J.E.Manno, M.J.Wood, B.R.Manno, and M.E.Mims, (1988). Comparison of efficacy of ginger with various antimotion sickness drugs. Clin. Res. Pr. Drug Regul. Aff. 6:129–136.
51. K.L.Wu, C.K.Rayner, S.K.Chuah, C.S.Changchien, S.N.Lu, Y.C.Chiu, K.W.Chiu, and C.M.Lee, (2008). Effects of ginger on gastric emptying and motility in healthy humans. Eur. J. Gastroenterol. Hepatol. 20:436–440.
52. J.Yamahara, Q.R.Huang, Y.H.Li, L.Xu, and H.Fujimura, (1990). Gastrointestinal motility enhancing effect of ginger and its active constituents. Chem. Pharm. Bull. (Tokyo). 38:430–431.
53. J.Yamahara, H.Q.Rong, M.Iwamoto, G.Kobayashi, H.Matsuda, and H.Fujimura, (1989). Active components of ginger exhibiting antiserotonergic action. Phytotherapy Res. 3:70–71.
54. S.M.Zick, D.K.Turgeon, S.K.Vareed, M.T.Ruffin, A.J.Litzinger, B.D.Wright, S.Alrawi, D.P.Normolle, Z.Djuric, and D.E.Brenner, (2011). Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer. Cancer Prev. Res. (Phila). 4:1929–1937.